Relyvrio sodium phenylbutyrate 3 g and taurursodiol 1 g in single-dose packets for oral suspension Images
Generic Name: sodium phenylbutyrate/taurursodiol
This medication has been identified as Relyvrio sodium phenylbutyrate 3 g and taurursodiol 1 g in single-dose packets for oral suspension. It is supplied by Amylyx Pharmaceuticals, Inc.
Relyvrio is used in the treatment of Amyotrophic Lateral Sclerosis and belongs to the drug class miscellaneous central nervous system agents. Relyvrio sodium phenylbutyrate 3 g and taurursodiol 1 g in single-dose packets for oral suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Relyvrio
- Generic Name
- sodium phenylbutyrate/taurursodiol
- Strength
- sodium phenylbutyrate 3 g and taurursodiol 1 g in single-dose packets for oral suspension
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amylyx Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 73063-0035
More about Relyvrio (sodium phenylbutyrate / taurursodiol)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
